COVID-19 Impact on Global CAR T-Cell Immunotherapy Market Size, Status and Forecast 2020-2026
![](/report_cover/6975/covid-19-impact-on-global-car-t-cell-immunotherapy-market-size-status-n-forecast-2020-2026_en.gif)
This report focuses on the global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CAR T-Cell Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
The key players covered in this study
- AbbVie
- Celgene
- Kite Pharma
- Oxford BioMedica
- Novartis
- Gilead
- Pfizer
- Cellectis
- Bellicum
- Mustang Bio
- CARsgen Therapeutics
- Xyphos
- Minerva Biotechnologies
- Adaptimmune
- Ziopharm Oncology
- Aurora Biopharma
- Creative Biolabs
- Monotherapy
- Combination Therapy
- Hematologic Malignancies
- Solid Malignancies
- North America
- Europe
- China
- Japan
- Southeast Asia
- India
- Central & South America
- To analyze global CAR T-Cell Immunotherapy status, future forecast, growth opportunity, key market and key players.
- To present the CAR T-Cell Immunotherapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
- To strategically profile the key players and comprehensively analyze their development plan and strategies.
- To define, describe and forecast the market by type, market and key regions.
- History Year: 2015-2019
- Base Year: 2019
- Estimated Year: 2020
- Forecast Year 2020 to 2026
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Hematologic Malignancies
1.5.3 Solid Malignancies
1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
1.6.1 How the Covid-19 is Affecting the CAR T-Cell Immunotherapy Industry
1.6.1.1 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 CAR T-Cell Immunotherapy Market Perspective (2015-2026)
2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
2.2.1 CAR T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CAR T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 CAR T-Cell Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key CAR T-Cell Immunotherapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top CAR T-Cell Immunotherapy Players by Market Size
3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CAR T-Cell Immunotherapy Market Concentration Ratio
3.2.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2019
3.3 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.4 Key Players CAR T-Cell Immunotherapy Product Solution and Service
3.5 Date of Enter into CAR T-Cell Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)
5 CAR T-CELL IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America CAR T-Cell Immunotherapy Market Size (2015-2020)
6.2 CAR T-Cell Immunotherapy Key Players in North America (2019-2020)
6.3 North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
6.4 North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe CAR T-Cell Immunotherapy Market Size (2015-2020)
7.2 CAR T-Cell Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
7.4 Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
8 CHINA
8.1 China CAR T-Cell Immunotherapy Market Size (2015-2020)
8.2 CAR T-Cell Immunotherapy Key Players in China (2019-2020)
8.3 China CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
8.4 China CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan CAR T-Cell Immunotherapy Market Size (2015-2020)
9.2 CAR T-Cell Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
9.4 Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2015-2020)
10.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
11 INDIA
11.1 India CAR T-Cell Immunotherapy Market Size (2015-2020)
11.2 CAR T-Cell Immunotherapy Key Players in India (2019-2020)
11.3 India CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
11.4 India CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America CAR T-Cell Immunotherapy Market Size (2015-2020)
12.2 CAR T-Cell Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
13.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Celgene
13.2.1 Celgene Company Details
13.2.2 Celgene Business Overview and Its Total Revenue
13.2.3 Celgene CAR T-Cell Immunotherapy Introduction
13.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.2.5 Celgene Recent Development
13.3 Kite Pharma
13.3.1 Kite Pharma Company Details
13.3.2 Kite Pharma Business Overview and Its Total Revenue
13.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
13.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.3.5 Kite Pharma Recent Development
13.4 Oxford BioMedica
13.4.1 Oxford BioMedica Company Details
13.4.2 Oxford BioMedica Business Overview and Its Total Revenue
13.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
13.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.4.5 Oxford BioMedica Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview and Its Total Revenue
13.5.3 Novartis CAR T-Cell Immunotherapy Introduction
13.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Gilead
13.6.1 Gilead Company Details
13.6.2 Gilead Business Overview and Its Total Revenue
13.6.3 Gilead CAR T-Cell Immunotherapy Introduction
13.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.6.5 Gilead Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview and Its Total Revenue
13.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
13.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Cellectis
13.8.1 Cellectis Company Details
13.8.2 Cellectis Business Overview and Its Total Revenue
13.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
13.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.8.5 Cellectis Recent Development
13.9 Bellicum
13.9.1 Bellicum Company Details
13.9.2 Bellicum Business Overview and Its Total Revenue
13.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
13.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.9.5 Bellicum Recent Development
13.10 Mustang Bio
13.10.1 Mustang Bio Company Details
13.10.2 Mustang Bio Business Overview and Its Total Revenue
13.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
13.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.10.5 Mustang Bio Recent Development
13.11 CARsgen Therapeutics
10.11.1 CARsgen Therapeutics Company Details
10.11.2 CARsgen Therapeutics Business Overview and Its Total Revenue
10.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
10.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.11.5 CARsgen Therapeutics Recent Development
13.12 Xyphos
10.12.1 Xyphos Company Details
10.12.2 Xyphos Business Overview and Its Total Revenue
10.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
10.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.12.5 Xyphos Recent Development
13.13 Minerva Biotechnologies
10.13.1 Minerva Biotechnologies Company Details
10.13.2 Minerva Biotechnologies Business Overview and Its Total Revenue
10.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
10.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.13.5 Minerva Biotechnologies Recent Development
13.14 Adaptimmune
10.14.1 Adaptimmune Company Details
10.14.2 Adaptimmune Business Overview and Its Total Revenue
10.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
10.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.14.5 Adaptimmune Recent Development
13.15 Ziopharm Oncology
10.15.1 Ziopharm Oncology Company Details
10.15.2 Ziopharm Oncology Business Overview and Its Total Revenue
10.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
10.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.15.5 Ziopharm Oncology Recent Development
13.16 Aurora Biopharma
10.16.1 Aurora Biopharma Company Details
10.16.2 Aurora Biopharma Business Overview and Its Total Revenue
10.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
10.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.16.5 Aurora Biopharma Recent Development
13.17 Creative Biolabs
10.17.1 Creative Biolabs Company Details
10.17.2 Creative Biolabs Business Overview and Its Total Revenue
10.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
10.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.17.5 Creative Biolabs Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
1.4 Market Analysis by Type
1.4.1 Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Monotherapy
1.4.3 Combination Therapy
1.5 Market by Application
1.5.1 Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
1.5.2 Hematologic Malignancies
1.5.3 Solid Malignancies
1.6 Coronavirus Disease 2019 (Covid-19): CAR T-Cell Immunotherapy Industry Impact
1.6.1 How the Covid-19 is Affecting the CAR T-Cell Immunotherapy Industry
1.6.1.1 CAR T-Cell Immunotherapy Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and CAR T-Cell Immunotherapy Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 CAR T-Cell Immunotherapy Market Perspective (2015-2026)
2.2 CAR T-Cell Immunotherapy Growth Trends by Regions
2.2.1 CAR T-Cell Immunotherapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 CAR T-Cell Immunotherapy Historic Market Share by Regions (2015-2020)
2.2.3 CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 CAR T-Cell Immunotherapy Market Growth Strategy
2.3.6 Primary Interviews with Key CAR T-Cell Immunotherapy Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top CAR T-Cell Immunotherapy Players by Market Size
3.1.1 Global Top CAR T-Cell Immunotherapy Players by Revenue (2015-2020)
3.1.2 Global CAR T-Cell Immunotherapy Revenue Market Share by Players (2015-2020)
3.1.3 Global CAR T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CAR T-Cell Immunotherapy Market Concentration Ratio
3.2.1 Global CAR T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by CAR T-Cell Immunotherapy Revenue in 2019
3.3 CAR T-Cell Immunotherapy Key Players Head office and Area Served
3.4 Key Players CAR T-Cell Immunotherapy Product Solution and Service
3.5 Date of Enter into CAR T-Cell Immunotherapy Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global CAR T-Cell Immunotherapy Historic Market Size by Type (2015-2020)
4.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Type (2021-2026)
5 CAR T-CELL IMMUNOTHERAPY BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
5.2 Global CAR T-Cell Immunotherapy Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America CAR T-Cell Immunotherapy Market Size (2015-2020)
6.2 CAR T-Cell Immunotherapy Key Players in North America (2019-2020)
6.3 North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
6.4 North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe CAR T-Cell Immunotherapy Market Size (2015-2020)
7.2 CAR T-Cell Immunotherapy Key Players in Europe (2019-2020)
7.3 Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
7.4 Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
8 CHINA
8.1 China CAR T-Cell Immunotherapy Market Size (2015-2020)
8.2 CAR T-Cell Immunotherapy Key Players in China (2019-2020)
8.3 China CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
8.4 China CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan CAR T-Cell Immunotherapy Market Size (2015-2020)
9.2 CAR T-Cell Immunotherapy Key Players in Japan (2019-2020)
9.3 Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
9.4 Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia CAR T-Cell Immunotherapy Market Size (2015-2020)
10.2 CAR T-Cell Immunotherapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
10.4 Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
11 INDIA
11.1 India CAR T-Cell Immunotherapy Market Size (2015-2020)
11.2 CAR T-Cell Immunotherapy Key Players in India (2019-2020)
11.3 India CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
11.4 India CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America CAR T-Cell Immunotherapy Market Size (2015-2020)
12.2 CAR T-Cell Immunotherapy Key Players in Central & South America (2019-2020)
12.3 Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020)
12.4 Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 AbbVie
13.1.1 AbbVie Company Details
13.1.2 AbbVie Business Overview and Its Total Revenue
13.1.3 AbbVie CAR T-Cell Immunotherapy Introduction
13.1.4 AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020))
13.1.5 AbbVie Recent Development
13.2 Celgene
13.2.1 Celgene Company Details
13.2.2 Celgene Business Overview and Its Total Revenue
13.2.3 Celgene CAR T-Cell Immunotherapy Introduction
13.2.4 Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.2.5 Celgene Recent Development
13.3 Kite Pharma
13.3.1 Kite Pharma Company Details
13.3.2 Kite Pharma Business Overview and Its Total Revenue
13.3.3 Kite Pharma CAR T-Cell Immunotherapy Introduction
13.3.4 Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.3.5 Kite Pharma Recent Development
13.4 Oxford BioMedica
13.4.1 Oxford BioMedica Company Details
13.4.2 Oxford BioMedica Business Overview and Its Total Revenue
13.4.3 Oxford BioMedica CAR T-Cell Immunotherapy Introduction
13.4.4 Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.4.5 Oxford BioMedica Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview and Its Total Revenue
13.5.3 Novartis CAR T-Cell Immunotherapy Introduction
13.5.4 Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Gilead
13.6.1 Gilead Company Details
13.6.2 Gilead Business Overview and Its Total Revenue
13.6.3 Gilead CAR T-Cell Immunotherapy Introduction
13.6.4 Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.6.5 Gilead Recent Development
13.7 Pfizer
13.7.1 Pfizer Company Details
13.7.2 Pfizer Business Overview and Its Total Revenue
13.7.3 Pfizer CAR T-Cell Immunotherapy Introduction
13.7.4 Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.7.5 Pfizer Recent Development
13.8 Cellectis
13.8.1 Cellectis Company Details
13.8.2 Cellectis Business Overview and Its Total Revenue
13.8.3 Cellectis CAR T-Cell Immunotherapy Introduction
13.8.4 Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.8.5 Cellectis Recent Development
13.9 Bellicum
13.9.1 Bellicum Company Details
13.9.2 Bellicum Business Overview and Its Total Revenue
13.9.3 Bellicum CAR T-Cell Immunotherapy Introduction
13.9.4 Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.9.5 Bellicum Recent Development
13.10 Mustang Bio
13.10.1 Mustang Bio Company Details
13.10.2 Mustang Bio Business Overview and Its Total Revenue
13.10.3 Mustang Bio CAR T-Cell Immunotherapy Introduction
13.10.4 Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
13.10.5 Mustang Bio Recent Development
13.11 CARsgen Therapeutics
10.11.1 CARsgen Therapeutics Company Details
10.11.2 CARsgen Therapeutics Business Overview and Its Total Revenue
10.11.3 CARsgen Therapeutics CAR T-Cell Immunotherapy Introduction
10.11.4 CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.11.5 CARsgen Therapeutics Recent Development
13.12 Xyphos
10.12.1 Xyphos Company Details
10.12.2 Xyphos Business Overview and Its Total Revenue
10.12.3 Xyphos CAR T-Cell Immunotherapy Introduction
10.12.4 Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.12.5 Xyphos Recent Development
13.13 Minerva Biotechnologies
10.13.1 Minerva Biotechnologies Company Details
10.13.2 Minerva Biotechnologies Business Overview and Its Total Revenue
10.13.3 Minerva Biotechnologies CAR T-Cell Immunotherapy Introduction
10.13.4 Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.13.5 Minerva Biotechnologies Recent Development
13.14 Adaptimmune
10.14.1 Adaptimmune Company Details
10.14.2 Adaptimmune Business Overview and Its Total Revenue
10.14.3 Adaptimmune CAR T-Cell Immunotherapy Introduction
10.14.4 Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.14.5 Adaptimmune Recent Development
13.15 Ziopharm Oncology
10.15.1 Ziopharm Oncology Company Details
10.15.2 Ziopharm Oncology Business Overview and Its Total Revenue
10.15.3 Ziopharm Oncology CAR T-Cell Immunotherapy Introduction
10.15.4 Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.15.5 Ziopharm Oncology Recent Development
13.16 Aurora Biopharma
10.16.1 Aurora Biopharma Company Details
10.16.2 Aurora Biopharma Business Overview and Its Total Revenue
10.16.3 Aurora Biopharma CAR T-Cell Immunotherapy Introduction
10.16.4 Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.16.5 Aurora Biopharma Recent Development
13.17 Creative Biolabs
10.17.1 Creative Biolabs Company Details
10.17.2 Creative Biolabs Business Overview and Its Total Revenue
10.17.3 Creative Biolabs CAR T-Cell Immunotherapy Introduction
10.17.4 Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020)
10.17.5 Creative Biolabs Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. CAR T-Cell Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
Table 3. Ranking of Global Top CAR T-Cell Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. COVID-19 Impact Global Market: (Four CAR T-Cell Immunotherapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for CAR T-Cell Immunotherapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
Table 12. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global CAR T-Cell Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global CAR T-Cell Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Market Share by Regions (2015-2020)
Table 16. Global CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global CAR T-Cell Immunotherapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. CAR T-Cell Immunotherapy Market Growth Strategy
Table 22. Main Points Interviewed from Key CAR T-Cell Immunotherapy Players
Table 23. Global CAR T-Cell Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global CAR T-Cell Immunotherapy Market Share by Players (2015-2020)
Table 25. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019)
Table 26. Global CAR T-Cell Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players CAR T-Cell Immunotherapy Product Solution and Service
Table 29. Date of Enter into CAR T-Cell Immunotherapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global CAR T-Cell Immunotherapy Market Size Share by Type (2015-2020)
Table 33. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2021-2026)
Table 34. Global CAR T-Cell Immunotherapy Market Size Share by Application (2015-2020)
Table 35. Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global CAR T-Cell Immunotherapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 39. North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 41. North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 43. Europe Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 45. Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 47. Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 49. China Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 51. China CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 52. China CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 53. China CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 54. China CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 55. Japan Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 57. Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 59. Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 63. Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 65. Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 67. India Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 69. India CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 70. India CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 71. India CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 72. India CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 75. Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 77. Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Product
Table 87. Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 88. Celgene Recent Development
Table 89. Kite Pharma Company Details
Table 90. Kite Pharma Business Overview
Table 91. Kite Pharma Product
Table 92. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 93. Kite Pharma Recent Development
Table 94. Oxford BioMedica Company Details
Table 95. Oxford BioMedica Business Overview
Table 96. Oxford BioMedica Product
Table 97. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 98. Oxford BioMedica Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Gilead Company Details
Table 105. Gilead Business Overview
Table 106. Gilead Product
Table 107. Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 108. Gilead Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Product
Table 112. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 113. Pfizer Recent Development
Table 114. Cellectis Business Overview
Table 115. Cellectis Product
Table 116. Cellectis Company Details
Table 117. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 118. Cellectis Recent Development
Table 119. Bellicum Company Details
Table 120. Bellicum Business Overview
Table 121. Bellicum Product
Table 122. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 123. Bellicum Recent Development
Table 124. Mustang Bio Company Details
Table 125. Mustang Bio Business Overview
Table 126. Mustang Bio Product
Table 127. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 128. Mustang Bio Recent Development
Table 129. CARsgen Therapeutics Company Details
Table 130. CARsgen Therapeutics Business Overview
Table 131. CARsgen Therapeutics Product
Table 132. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 133. CARsgen Therapeutics Recent Development
Table 134. Xyphos Company Details
Table 135. Xyphos Business Overview
Table 136. Xyphos Product
Table 137. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 138. Xyphos Recent Development
Table 139. Minerva Biotechnologies Company Details
Table 140. Minerva Biotechnologies Business Overview
Table 141. Minerva Biotechnologies Product
Table 142. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 143. Minerva Biotechnologies Recent Development
Table 144. Adaptimmune Company Details
Table 145. Adaptimmune Business Overview
Table 146. Adaptimmune Product
Table 147. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 148. Adaptimmune Recent Development
Table 149. Ziopharm Oncology Company Details
Table 150. Ziopharm Oncology Business Overview
Table 151. Ziopharm Oncology Product
Table 152. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 153. Ziopharm Oncology Recent Development
Table 154. Aurora Biopharma Company Details
Table 155. Aurora Biopharma Business Overview
Table 156. Aurora Biopharma Product
Table 157. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 158. Aurora Biopharma Recent Development
Table 159. Creative Biolabs Company Details
Table 160. Creative Biolabs Business Overview
Table 161. Creative Biolabs Product
Table 162. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 163. Creative Biolabs Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
Table 1. CAR T-Cell Immunotherapy Key Market Segments
Table 2. Key Players Covered: Ranking by CAR T-Cell Immunotherapy Revenue
Table 3. Ranking of Global Top CAR T-Cell Immunotherapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CAR T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monotherapy
Table 6. Key Players of Combination Therapy
Table 7. COVID-19 Impact Global Market: (Four CAR T-Cell Immunotherapy Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for CAR T-Cell Immunotherapy Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for CAR T-Cell Immunotherapy Players to Combat Covid-19 Impact
Table 12. Global CAR T-Cell Immunotherapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global CAR T-Cell Immunotherapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global CAR T-Cell Immunotherapy Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global CAR T-Cell Immunotherapy Market Share by Regions (2015-2020)
Table 16. Global CAR T-Cell Immunotherapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global CAR T-Cell Immunotherapy Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. CAR T-Cell Immunotherapy Market Growth Strategy
Table 22. Main Points Interviewed from Key CAR T-Cell Immunotherapy Players
Table 23. Global CAR T-Cell Immunotherapy Revenue by Players (2015-2020) (Million US$)
Table 24. Global CAR T-Cell Immunotherapy Market Share by Players (2015-2020)
Table 25. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019)
Table 26. Global CAR T-Cell Immunotherapy by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players CAR T-Cell Immunotherapy Product Solution and Service
Table 29. Date of Enter into CAR T-Cell Immunotherapy Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 32. Global CAR T-Cell Immunotherapy Market Size Share by Type (2015-2020)
Table 33. Global CAR T-Cell Immunotherapy Revenue Market Share by Type (2021-2026)
Table 34. Global CAR T-Cell Immunotherapy Market Size Share by Application (2015-2020)
Table 35. Global CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 36. Global CAR T-Cell Immunotherapy Market Size Share by Application (2021-2026)
Table 37. North America Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 38. North America Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 39. North America CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 40. North America CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 41. North America CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 42. North America CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 43. Europe Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 45. Europe CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 46. Europe CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 47. Europe CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 48. Europe CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 49. China Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 50. China Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 51. China CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 52. China CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 53. China CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 54. China CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 55. Japan Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 57. Japan CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 58. Japan CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 59. Japan CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 60. Japan CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 63. Southeast Asia CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 65. Southeast Asia CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 67. India Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 68. India Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 69. India CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 70. India CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 71. India CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 72. India CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 73. Central & South America Key Players CAR T-Cell Immunotherapy Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players CAR T-Cell Immunotherapy Market Share (2019-2020)
Table 75. Central & South America CAR T-Cell Immunotherapy Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America CAR T-Cell Immunotherapy Market Share by Type (2015-2020)
Table 77. Central & South America CAR T-Cell Immunotherapy Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America CAR T-Cell Immunotherapy Market Share by Application (2015-2020)
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Celgene Company Details
Table 85. Celgene Business Overview
Table 86. Celgene Product
Table 87. Celgene Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 88. Celgene Recent Development
Table 89. Kite Pharma Company Details
Table 90. Kite Pharma Business Overview
Table 91. Kite Pharma Product
Table 92. Kite Pharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 93. Kite Pharma Recent Development
Table 94. Oxford BioMedica Company Details
Table 95. Oxford BioMedica Business Overview
Table 96. Oxford BioMedica Product
Table 97. Oxford BioMedica Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 98. Oxford BioMedica Recent Development
Table 99. Novartis Company Details
Table 100. Novartis Business Overview
Table 101. Novartis Product
Table 102. Novartis Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 103. Novartis Recent Development
Table 104. Gilead Company Details
Table 105. Gilead Business Overview
Table 106. Gilead Product
Table 107. Gilead Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 108. Gilead Recent Development
Table 109. Pfizer Company Details
Table 110. Pfizer Business Overview
Table 111. Pfizer Product
Table 112. Pfizer Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 113. Pfizer Recent Development
Table 114. Cellectis Business Overview
Table 115. Cellectis Product
Table 116. Cellectis Company Details
Table 117. Cellectis Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 118. Cellectis Recent Development
Table 119. Bellicum Company Details
Table 120. Bellicum Business Overview
Table 121. Bellicum Product
Table 122. Bellicum Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 123. Bellicum Recent Development
Table 124. Mustang Bio Company Details
Table 125. Mustang Bio Business Overview
Table 126. Mustang Bio Product
Table 127. Mustang Bio Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 128. Mustang Bio Recent Development
Table 129. CARsgen Therapeutics Company Details
Table 130. CARsgen Therapeutics Business Overview
Table 131. CARsgen Therapeutics Product
Table 132. CARsgen Therapeutics Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 133. CARsgen Therapeutics Recent Development
Table 134. Xyphos Company Details
Table 135. Xyphos Business Overview
Table 136. Xyphos Product
Table 137. Xyphos Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 138. Xyphos Recent Development
Table 139. Minerva Biotechnologies Company Details
Table 140. Minerva Biotechnologies Business Overview
Table 141. Minerva Biotechnologies Product
Table 142. Minerva Biotechnologies Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 143. Minerva Biotechnologies Recent Development
Table 144. Adaptimmune Company Details
Table 145. Adaptimmune Business Overview
Table 146. Adaptimmune Product
Table 147. Adaptimmune Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 148. Adaptimmune Recent Development
Table 149. Ziopharm Oncology Company Details
Table 150. Ziopharm Oncology Business Overview
Table 151. Ziopharm Oncology Product
Table 152. Ziopharm Oncology Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 153. Ziopharm Oncology Recent Development
Table 154. Aurora Biopharma Company Details
Table 155. Aurora Biopharma Business Overview
Table 156. Aurora Biopharma Product
Table 157. Aurora Biopharma Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 158. Aurora Biopharma Recent Development
Table 159. Creative Biolabs Company Details
Table 160. Creative Biolabs Business Overview
Table 161. Creative Biolabs Product
Table 162. Creative Biolabs Revenue in CAR T-Cell Immunotherapy Business (2015-2020) (Million US$)
Table 163. Creative Biolabs Recent Development
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
Figure 5. Hematologic Malignancies Case Studies
Figure 6. Solid Malignancies Case Studies
Figure 7. CAR T-Cell Immunotherapy Report Years Considered
Figure 8. Global CAR T-Cell Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global CAR T-Cell Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 10. Global CAR T-Cell Immunotherapy Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global CAR T-Cell Immunotherapy Market Share by Players in 2019
Figure 13. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2019
Figure 15. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 24. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 26. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 28. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 32. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 36. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 38. Bellicum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 40. Mustang Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 42. CARsgen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 44. Xyphos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 46. Minerva Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 48. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 50. Ziopharm Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 52. Aurora Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 54. Creative Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Figure 1. Global CAR T-Cell Immunotherapy Market Share by Type: 2020 VS 2026
Figure 2. Monotherapy Features
Figure 3. Combination Therapy Features
Figure 4. Global CAR T-Cell Immunotherapy Market Share by Application: 2020 VS 2026
Figure 5. Hematologic Malignancies Case Studies
Figure 6. Solid Malignancies Case Studies
Figure 7. CAR T-Cell Immunotherapy Report Years Considered
Figure 8. Global CAR T-Cell Immunotherapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global CAR T-Cell Immunotherapy Market Share by Regions: 2020 VS 2026
Figure 10. Global CAR T-Cell Immunotherapy Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global CAR T-Cell Immunotherapy Market Share by Players in 2019
Figure 13. Global Top CAR T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CAR T-Cell Immunotherapy as of 2019
Figure 14. The Top 10 and 5 Players Market Share by CAR T-Cell Immunotherapy Revenue in 2019
Figure 15. North America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America CAR T-Cell Immunotherapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. AbbVie Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 24. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Celgene Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 26. Kite Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Kite Pharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 28. Oxford BioMedica Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Oxford BioMedica Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 30. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Novartis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 32. Gilead Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Gilead Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 34. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Pfizer Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 36. Cellectis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Cellectis Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 38. Bellicum Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Bellicum Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 40. Mustang Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Mustang Bio Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 42. CARsgen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. CARsgen Therapeutics Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 44. Xyphos Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Xyphos Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 46. Minerva Biotechnologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Minerva Biotechnologies Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 48. Adaptimmune Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Adaptimmune Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 50. Ziopharm Oncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Ziopharm Oncology Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 52. Aurora Biopharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Aurora Biopharma Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 54. Creative Biolabs Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Creative Biolabs Revenue Growth Rate in CAR T-Cell Immunotherapy Business (2015-2020)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed